Article
Optimization of nonmuscle invasive bladder cancer recurrence detection using a urine based FGFR3 mutation assay.
The Journal of urology - 1 Aug 2011
Zuiverloon Tahlita C M, Tjin Stephen S, Busstra Martijn, Bangma Chris H, Boevé Egbert R, Zwarthoff Ellen C
Abstract excerpt
PURPOSE: FGFR3 mutations occur in 70% of nonmuscle invasive bladder tumors. Although urine based FGFR3 mutation analysis can detect recurrence, its sensitivity may be limited if samples have few or no tumor cells. We determined whether test sensitivity depends on tumor size and the time point of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.